
Opinion|Videos|February 10, 2025
Management of Tardive Dyskinesia and Comorbidities
Panelists discuss how managing tardive dyskinesia in patients with comorbid mental health conditions requires a delicate balance between treating TD symptoms while maintaining psychiatric stability, emphasizing the importance of coordinated care between psychiatrists and movement disorder specialists to optimize medication regimens, monitor for potential drug interactions, and address the complex interplay between physical symptoms and psychological well-being.
Advertisement
Episodes in this series

Video series above is prompted by the following:
- How does the burden of comorbid conditions, such as mental health disorders, influence the management and outcomes of patients with TD?
- How does the long-term management of TD align with treatment strategies for other movement disorders, and what challenges or opportunities arise when managing coexisting conditions
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Circulating Tumor Cells May Guide Use of Tarlatamab in Small Cell Lung Cancer
2
Pharmacists Can Implement Test-and-Treat Services in Their Practice Settings
3
FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer
4
Recapping 2025 ASHP Midyear: Expanding the Pharmacist’s Role in Patient Care, Technology, and Health System Resilience
5


















































































































































































































